Ichor (ICHR) Prices 4M Share Upsized Common Offering at $31.75/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- CAE agrees to sell Flightscape unit to SITA for $500 million
Pre-Open Stock Movers 12/09: (MTSC) (RCKT) (QS) Higher; (PSTI) (PLAB) (GME) Lower (more...)
December 9, 2020 9:29 AM ESTToday's Pre-Open Stock Movers:
MTS Systems Corporation (Nasdaq: MTSC) 49% HIGHER; Amphenol Corporation (NYSE: APH) (Amphenol), a leading global provider of high-technology interconnect, antenna and sensor solutions,... More
After-Hours Stock Movers 12/08: (RCKT) (PRPH) (SDC) Higher; (GME) (DCTH) (TALO) Lower (more...)
December 8, 2020 5:41 PM ESTToday's After-Hours Stock Movers:
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) 33.4% HIGHER; announces preliminary data from its open-label, Phase 1 clinical trial of RP-A501, the Companys adeno-associated viral vector (AAV)-based gene therapy candidate expressing LAMP2B for the treatment of Danon Disease. Danon Disease is a rare X-linked inherited disorder caused by genetic mutations in the LAMP2 gene resulting in accumulation of autophagosomes and glycogen, particularly in cardiac muscle and other tissues, which ultimately leads to severe and frequently fatal cardiomyopathy. Preliminary data from patients in the low dose... More
Ichor Holdings (ICHR) to Offer 3.5M Shares
December 8, 2020 4:02 PM ESTIchor Holdings, Ltd. (NASDAQ: ICHR) commenced an underwritten public offering of 3,500,000 of its ordinary shares. In addition, the Company intends to grant the underwriters a 30-day option to purchase up to an additional 525,000 of its ordinary shares sold in the offering at the public offering... More



